Drug Profile
Dutasteride/tamsulosin - GL Pharmtech
Latest Information Update: 12 May 2015
Price :
$50
*
At a glance
- Originator GL PharmTech
- Class Amines; Antiandrogens; Azasteroids; Benzene derivatives; Ethers; Small molecules; Sulfonamides
- Mechanism of Action Alpha-1a adrenergic receptor antagonists; Cholestenone 5-alpha reductase inhibitors; Testosterone antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Benign prostatic hyperplasia
Most Recent Events
- 12 May 2015 No recent reports of development identified - Phase-III for Benign prostatic hyperplasia in South Korea (PO)
- 01 Oct 2011 Phase-III clinical trials in Benign prostatic hyperplasia in South Korea (PO)